Lifecore Biomedical (LFCR) Institutional Ownership

$6.60
-0.04 (-0.60%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Lifecore Biomedical (NASDAQ:LFCR)

Current
Institutional Ownership
Percentage
83.36%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$31.16M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$12.03M
Get LFCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LFCR Institutional Buying and Selling by Quarter

Lifecore Biomedical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Greenhaven Road Investment Management L.P.2,366,956$14.65M6.6%+7.9%7.806%
2/14/2024Visionary Wealth Advisors497,204$3.08M0.2%-0.8%1.640%
2/13/2024DCF Advisers LLC259,684$1.61M0.9%+115.1%0.856%
2/12/2024Cove Street Capital LLC910,264$5.64M1.7%-17.7%3.002%
2/1/2024Cutter & CO Brokerage Inc.15,567$96K0.0%-28.3%0.051%
1/30/2024 Keene & Associates Inc.21,935$136K0.1%-8.4%0.072%
12/6/2023Citigroup Inc.33,618$254K0.0%+2,311.6%0.111%
11/21/2023Greenhaven Road Investment Management L.P.2,193,333$16.55M8.4%+15.3%7.234%
11/14/2023Trexquant Investment LP47,157$356K0.0%N/A0.156%
11/13/2023Visionary Wealth Advisors501,334$3.78M0.3%+0.4%1.653%
11/9/2023HAP Trading LLC163,773$1.24M0.2%-82.6%0.540%
11/9/2023Cove Street Capital LLC1,105,556$8.35M2.8%-31.7%3.646%
11/9/2023Tocqueville Asset Management L.P.401,700$3.03M0.1%-11.1%1.325%
11/8/2023Oppenheimer Asset Management Inc.33,532$253K0.0%-48.4%0.111%
11/7/2023Barclays PLC30,911$233K0.0%+244.8%0.102%
11/7/2023Jump Financial LLC36,918$279K0.0%N/A0.122%
11/6/2023 Assenagon Asset Management S.A.23,852$180K0.0%-68.4%0.079%
10/24/2023Bank of New York Mellon Corp24,615$186K0.0%-7.9%0.081%
9/21/2023Barclays PLC8,965$87K0.0%N/A0.030%
8/15/2023Corsair Capital Management L.P.122,431$1.18M0.4%N/A0.404%
8/11/2023Cove Street Capital LLC1,619,536$15.66M4.9%N/A5.341%
8/11/2023Visionary Wealth Advisors499,309$4.83M0.4%N/A1.647%
8/10/2023Gamco Investors INC. ET AL76,500$740K0.0%N/A0.252%
8/10/2023Gabelli Funds LLC16,600$161K0.0%N/A0.055%
8/7/2023Mirabella Financial Services LLP15,413$149K0.0%N/A0.051%
8/3/2023Oppenheimer Asset Management Inc.64,975$628K0.0%N/A0.214%
8/1/2023Cutter & CO Brokerage Inc.21,700$210K0.1%N/A0.072%
7/26/2023 Keene & Associates Inc.24,100$233K0.2%N/A0.079%
7/25/2023 Assenagon Asset Management S.A.75,391$729K0.0%N/A0.249%
7/18/2023Defender Capital LLC.86,450$836K0.3%N/A0.285%
7/18/2023 Diversified Trust Co46,062$445K0.0%N/A0.152%
6/1/2023Prelude Capital Management LLC21,295$80K0.0%N/A0.070%
(Data available from 1/1/2016 forward)

LFCR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LFCR shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Lifecore Biomedical. The most heavily invested institutionals were Greenhaven Road Investment Management L.P. ($14.65M), Cove Street Capital LLC ($5.64M), Visionary Wealth Advisors ($3.08M), Tocqueville Asset Management L.P. ($3.03M), DCF Advisers LLC ($1.61M), HAP Trading LLC ($1.24M), and Corsair Capital Management L.P. ($1.18M).Learn more on LFCR's institutional investors.

What percentage of Lifecore Biomedical stock is owned by institutional investors?

83.36% of Lifecore Biomedical stock is owned by institutional investors. Learn more on LFCR's institutional investor holdings.

Which institutional investors have been buying Lifecore Biomedical stock?

Of the 19 institutional investors that purchased Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cove Street Capital LLC ($1.62M), Visionary Wealth Advisors ($501.33K), Greenhaven Road Investment Management L.P. ($464.32K), DCF Advisers LLC ($138.93K), Corsair Capital Management L.P. ($122.43K), Defender Capital LLC. ($86.45K), and Gamco Investors INC. ET AL ($76.50K).

How much institutional buying is happening at Lifecore Biomedical?

Institutional investors have bought a total of 3,442,244 shares in the last 24 months. This purchase volume represents approximately $31.16M in transactions.

Which Lifecore Biomedical major shareholders have been selling company stock?

Of the 9 institutional investors that sold Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: HAP Trading LLC ($775.53K), Cove Street Capital LLC ($709.27K), Assenagon Asset Management S.A. ($51.54K), Tocqueville Asset Management L.P. ($50K), Oppenheimer Asset Management Inc. ($31.44K), Cutter & CO Brokerage Inc. ($6.13K), and Visionary Wealth Advisors ($4.13K).

How much institutional selling is happening at Lifecore Biomedical?

Institutional investors have sold a total of 1,632,149 shares in the last 24 months. This volume of shares sold represents approximately $12.03M in transactions.


This page (NASDAQ:LFCR) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners